CD11b+/Gr-1+ cells can facilitate tumor growth by virtue of their ability to downregulate the immune responses in subtypes of T-cells such as CD4+ and CD8+ cells; hence, the denomination of MDSCs for at least a subset of CD11b+/Gr1+ cells33. Here, CD4 is linked to neoplasm.